Literature DB >> 27504278

The Long Term Kinetic of Plasma Lipids and Lipoproteins in Tyloxapol Injected Rats.

Mehdi Rasouli1, Hanieh Tahmouri1, Mahboobeh Mosavi-Mehr1.   

Abstract

INTRODUCTION: The level of plasma triglyceride is balanced by the rate of secretion into and clearance from the plasma. Tyloxapol (Triton WR1339) is a nonionic detergent that inhibits lipoprotein lipase and hence clearance of triglyceride from the plasma. AIM: To determine the kinetic of plasma lipids and lipoproteins following injection of tyloxapol over a period of two weeks.
MATERIALS AND METHODS: Fifteen male rats were starved over-night and injected intravenously with tyloxapol (400mg/kg). Blood samples were taken in three steps as, the early (1-6 hours), the middle (1-2 days) and the third (3-9 days) phase. Plasma total cholesterol and triglyceride were measured by enzymatic methods and total phospholipids were analysed as molybdenum blue. Serum lipoproteins were fractionated by electrophoresis on agarose gel (Sebia Inc).
RESULTS: The changes of plasma lipids following tyloxapol injection showed three distinctive phases. The early phase lasts at least 6 hours, and the concentrations of triglyceride, total cholesterol and phospholipids increased linearly. The rate of triglyceride secretion was 259.7 ± 8.1 mg/h.dl in this phase, which was comparable to the mean rate of 250.6 ± 37.0 mg/h.dl or 102.8 ± 15.2 mg/h.kg body in starved male rat. During the next 48 hour the lipids continued to accumulate but at a lower rate, and the levels of triglyceride, cholesterol and total phospholipids rose up to about 3200, 586 and 715 mg/dl respectively. In the last phase, the levels of plasma lipids decreased toward the basal levels after 5 days. In serum lipoprotein electrophoresis, the VLDL and LDL increased and HDL fraction disappeared simultaneously during the initial 2 hours of tyloxapol injection. The VLDL fell down toward the normal range, preceded to the reappearance of HDL during 5 days.
CONCLUSION: A single intravenous injection of tyloxapol shows three distinctive phases. In the early phase, triglyceride accumulates linearly and the rate of its increment in plasma is a good estimate of the rate of VLDL secretion from the liver.

Entities:  

Keywords:  Cholesterol; Liver; Phospholipid; Triglyceride; Triton

Year:  2016        PMID: 27504278      PMCID: PMC4963638          DOI: 10.7860/JCDR/2016/18890.7993

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  28 in total

1.  Suppression of VLDL associated triacylglycerol secretion by both alpha- and beta-adrenoceptor agonists in isolated rat hepatocytes.

Authors:  Mehdi Rasouli; Mahin Zahraie
Journal:  Eur J Pharmacol       Date:  2006-07-05       Impact factor: 4.432

2.  A procedure for inducing sustained hyperlipemia in rats by administration of a surfactant.

Authors:  Seymour Levine; Arthur Saltzman
Journal:  J Pharmacol Toxicol Methods       Date:  2006-06-03       Impact factor: 1.950

3.  Triton WR-1339-induced changes in serum lipids and biliary lipid secretion.

Authors:  M Zeniya; A Reuben
Journal:  Am J Physiol       Date:  1988-03

4.  Isolation of very low density lipoprotein phospholipids enriched in ethanolamine phospholipids from rats injected with Triton WR 1339.

Authors:  Jyrki J Agren; Juha-Pekka Kurvinen; Arnis Kuksis
Journal:  Biochim Biophys Acta       Date:  2005-03-16

5.  Triacylglycerol accumulation and secretion in hepatocyte cultures. Effects of insulin, albumin and Triton WR 1339.

Authors:  N Emmison; V A Zammit; L Agius
Journal:  Biochem J       Date:  1992-07-15       Impact factor: 3.857

6.  Regulation of lipoprotein lipase in different rat tissues.

Authors:  M Kuwajima; D W Foster; J D McGarry
Journal:  Metabolism       Date:  1988-06       Impact factor: 8.694

7.  Rate of release of hepatic triacylglycerol into serum in the starved rat.

Authors:  J F Palmer; C Cooper; R A Shipley
Journal:  Biochem J       Date:  1978-05-15       Impact factor: 3.857

8.  Central nervous system neuropeptide Y signaling modulates VLDL triglyceride secretion.

Authors:  John M Stafford; Fang Yu; Richard Printz; Alyssa H Hasty; Larry L Swift; Kevin D Niswender
Journal:  Diabetes       Date:  2008-03-10       Impact factor: 9.461

9.  Effects of the lipase inhibitors, Triton WR-1339 and tetrahydrolipstatin, on the synthesis and secretion of lipids by rat hepatocytes.

Authors:  D Hermier; P Hales; D N Brindley
Journal:  FEBS Lett       Date:  1991-07-29       Impact factor: 4.124

10.  Secretion and storage of newly synthesized hepatic triacylglycerol fatty acids in vivo in different nutritional states and in diabetes.

Authors:  J M Duerden; G F Gibbons
Journal:  Biochem J       Date:  1988-11-01       Impact factor: 3.857

View more
  3 in total

1.  Comparison of Methods to Assay Liver Glycogen Fractions: The Effects of Starvation.

Authors:  Nastaran Mojibi; Mehdi Rasouli
Journal:  J Clin Diagn Res       Date:  2017-03-01

2.  The Ratio of Unesterified/esterified Cholesterol is the Major Determinant of Atherogenicity of Lipoprotein Fractions.

Authors:  Babak Bagheri; Asal Alikhani; Hossein Mokhtari; Mehdi Rasouli
Journal:  Med Arch       Date:  2018-04

3.  Fixed-time and continuous assays of very-low-density lipoprotein secretion rate from rat liver: mean vs. instantaneous velocity.

Authors:  Kousar Daneshnia; Mehdi Rasouli
Journal:  Clin Exp Hepatol       Date:  2021-05-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.